Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Moberg Adds DermoPlast Line With Bondholders' Blessing For More

Executive Summary

Moberg says sales of DermoPlast sprays were $12m in the 12 months through September and its purchase price is around 8.9 times the estimated EBITDA for the brand during the period.

Advertisement

Related Content

Moberg Sells Consumer Health Portfolio To Pay For Rx Research Focus
Moberg Sells Consumer Health Portfolio To Pay For Focusing On Rx Research
Prestige Brands' Business Is Exclusively OTC Drugs As It Completes House Cleaning
Prestige Brands' Business Is Exclusively OTC Drugs As It Completes House Cleaning
E.P.T. Pregnancy Test Will Get Marketing Bump From NFI Consumer
E.P.T. Pregnancy Test Will Get Marketing Bump From NFI Consumer
Prestige Brands Acquires C.B. Fleet, Boosts Women’s OTC Platform
Prestige Brands Acquires C.B. Fleet, Boosts Women’s OTC Platform
Consumer Industry Roundup: Catalent Acquires Accucaps; CHPA Adds Lobbyist; Zeasorb Recall
Moberg Sustains Derma Drive, Acquires Prestige Brands' New Skin

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS119637

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel